GlassScriptPhysician profile
Mohammad El-Hajjar
NPI 1073783577
$43,869.94
in general payments reported to CMS, 2019-2025
30 companies · $3,973 in 2025
The $3,973 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $13K · 2021: $3,937 · 2022: $896 · 2023: $619 · 2024: $776 · 2025: $3,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,442 · Travel and Lodging: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,442.23 |
| Travel and Lodging | $925.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31,681.94 | 2019-2025 | General - Therapies, Versacross Access Solution, Bodyguardian |
| Edwards Lifesciences Corporation | $4,560.61 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia |
| Siemens Medical Solutions USA, INC. | $3,429.20 | 2021 | |
| Abbott Laboratories | $2,082.58 | 2019-2025 | Navitor |
| Aop Health US, LLC | $966.78 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $210.04 | 2025 | |
| Abiomed | $85.00 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $72.87 | 2025 | |
| Angiodynamics, INC. | $72.00 | 2025 | Angiovac |
| Janssen Pharmaceuticals, INC | $71.24 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $64.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $60.99 | 2019-2025 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $60.55 | 2019-2025 | Evkeeza |
| Bridgebio Pharma, INC. | $57.04 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $54.55 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $43.58 | 2025 | Assure Wcd |
| Medicomp INC | $36.79 | 2025 | Telepatch Cardiac Monitor |
| Cardiovascular Systems INC. | $34.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $33.08 | 2019-2025 | Lokelma |
| Medtronic Vascular, INC. | $32.12 | 2020 | |
| Baxter Healthcare | $25.99 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Gilead Sciences, INC. | $18.47 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.16 | 2025 | Opsumit |
| Chiesi USA, INC. | $16.35 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.58 | 2025 | Jardiance |
| Cvrx, INC. | $14.46 | 2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $14.36 | 2024 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $14.22 | 2023 | Inpefa |
| B. Braun Interventional Systems INC. | $12.97 | 2023 | No Marketed Product Name |
| Portola Pharmaceuticals, LLC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad El-Hajjar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.